Shanghai UniXell Biotechnology
PrivateLast Round
Series A
Apr 18, 2025
Total Funding Raised
$71.38M
Company Overview
Shanghai UniXell Biotechnology is a biotechnology company that develops human pluripotent stem cell (hPSC) based cell therapies for neurodegenerative and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai UniXell Biotechnology Comparables
Compare Shanghai UniXell Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oryon Cell Therapies | 88% | |
| XellSmart | 87% | |
| iRegene Therapeutics | 86% | |
Shanghai UniXell Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 18, 2025 | ||||
| Series A | Jul 12, 2024 | ||||
| Series A | Apr 4, 2024 | ||||
| Pre Seed | Mar 14, 2022 | ||||
| Angel | Aug 25, 2021 |
Shanghai UniXell Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Pre Seed |
| Guokejiahe Fund | Series A |
| TF Capital | Pre Seed |
| CAS Venture Capital | Series A |
| Jiangsu Ruihua Investment Holding Group | Pre Seed |
| Kunlun Capital | Series A |
| Tasly Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2025
$19.18M round with participation from Guokejiahe Fund and Kunlun Capital.
- Jul 12, 2024
$1.38M round led by The Chinese Academy of Sciences Venture Capital Management
Shanghai UniXell Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai UniXell Biotechnology's valuation, stock price, and market status.